Published on 17 Oct 2024 on Benzinga · via Yahoo Finance
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce
On Thursday, Sage Therapeutics, Inc. (NASDAQ:SAGE) announced a strategic reorganization of its business operations to support the ongoing launch of Zurzuvae (zuranolone) in postpartum depression.
The reorganization is intended to enable Sage to strengthen its balance sheet, extend its cash runway, and position the company for long-term growth potential.